Ernest Choy

Active 1995–2026

143
Papers
26,866
Citations
86
h-index
138
i10-index

Citations

Citations per year for Ernest Choy1977: 1 citations1992: 1 citations1996: 5 citations1997: 16 citations1998: 10 citations1999: 14 citations2000: 7 citations2001: 10 citations2002: 33 citations2003: 47 citations2004: 56 citations2005: 51 citations2006: 80 citations2007: 100 citations2008: 99 citations2009: 133 citations2010: 195 citations2011: 186 citations2012: 169 citations2013: 173 citations2014: 205 citations2015: 219 citations2016: 208 citations2017: 216 citations2018: 220 citations2019: 781 citations2020: 920 citations2021: 1,006 citations2022: 814 citations2023: 685 citations2024: 1,082 citations2025: 508 citations2026: 21 citations1978–1991: no citations, so these years are not shown1993–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,229 citing papers, 17.9% of this breakdownUnited Kingdom: 1,261 citing papers, 10.1% of this breakdownChina: 830 citing papers, 6.7% of this breakdownGermany: 657 citing papers, 5.3% of this breakdownItaly: 642 citing papers, 5.2% of this breakdownFrance: 531 citing papers, 4.3% of this breakdownCanada: 530 citing papers, 4.2% of this breakdownNetherlands: 500 citing papers, 4% of this breakdownSpain: 472 citing papers, 3.8% of this breakdownJapan: 411 citing papers, 3.3% of this breakdownAustralia: 332 citing papers, 2.7% of this breakdownSweden: 287 citing papers, 2.3% of this breakdown
0%17.9%Other 30.2%

Fields

  • Medicine75.1%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Immunology and Microbiology7.5%
  • Neuroscience2.4%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Health Professions0.8%
  • Other3.4%

Topics

  • Rheumatoid Arthritis Research and Therapies12.1%
  • Fibromyalgia and Chronic Fatigue Syndrome Research4.8%
  • Spondyloarthritis Studies and Treatments4.6%
  • Systemic Lupus Erythematosus Research3.6%
  • Autoimmune and Inflammatory Disorders Research3.3%
  • Musculoskeletal pain and rehabilitation2.9%
  • Other68.7%

Coauthors

All papers

Open in search
  1. EULAR revised recommendations for the management of fibromyalgia

    Authors: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 1,502

  2. EULAR definition of difficult-to-treat rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 cited by 539

  3. Translating IL-6 biology into effective treatments

    Authors: , , , , , - Nature Reviews Rheumatology 2020 cited by 697

  4. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 cited by 279

  5. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis - The Lancet 2021 cited by 315

  6. Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2019 cited by 416

  7. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 cited by 276

  8. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 326

  9. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

    Authors: , - Seminars in Arthritis and Rheumatism 2020 cited by 313

  10. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

    Authors: , , , , , , - Seminars in Arthritis and Rheumatism 2020 cited by 215

  11. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

    Authors: - Lara D. Veeken 2012 cited by 832

  12. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

    Authors: , , , , , , , , - Neuromuscular Disorders 2004 cited by 937

  13. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 276

  14. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

    Authors: , - New England Journal of Medicine 2001 cited by 2,258

  15. Clinical significance of Janus Kinase inhibitor selectivity

    Authors: - Lara D. Veeken 2018 cited by 283

  16. Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases

    Authors: , , , , , , , , , - Lara D. Veeken 2023 cited by 93

  17. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison

    Authors: , , , , , - BMJ Open 2019 cited by 266

  18. Synovial tissue research: a state-of-the-art review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2017 cited by 257

  19. The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis

    Authors: , - Therapeutic Advances in Musculoskeletal Disease 2010 cited by 364

  20. The role of sleep in pain and fibromyalgia

    Authors: - Nature Reviews Rheumatology 2015 cited by 326

  21. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen - Annals of the Rheumatic Diseases 2022 cited by 69

  22. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claire Gorman, James Galloway, Hector Chinoy, Désirée van der Heijde, Peter Sasieni, Anne Barton, Costantino Pitzalis, Ahmed S Zayat, Ana Rita Marinho Machado, Andrea Cuervo, Arti Mahto, Cankut Çubuk, Charlotte Rawlings, Chijioke H Mosanya, Christopher D. Buckley, Chris Holroyd, Debbie Maskall, Francesco Carlucci, Georgina Thorborn, Gina Tan, Gloria Lliso-Ribera, Hasan Rizvi, Joanna Peel, João Eurico Fonseca, John D. Isaacs, Julio Ramírez, Laurent Méric de Bellefon, Liliane Fossati-Jimak, Mary Ng’endo Githinji, Mattia Congia, Neal L. Millar, Nirupam Purkayastha, Raquel Celis, Rakhi Seth, Rebecca Hands-Greenwood, Robert Landewé, Simone Perniola, Stefano Alivernini, Stefano Marcia, Stefano Marini, Stephen Kelly, Vasco C. Romão - The Lancet Rheumatology 2023 cited by 68

  23. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 128

  24. Transforming clinical trials in rheumatology: towards patient-centric precision medicine

    Authors: , , - Nature Reviews Rheumatology 2020 cited by 112